Compare HROW & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HROW | CCBG |
|---|---|---|
| Founded | 1998 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 828.1M |
| IPO Year | 2008 | 1994 |
| Metric | HROW | CCBG |
|---|---|---|
| Price | $28.30 | $50.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $62.63 | $51.83 |
| AVG Volume (30 Days) | ★ 635.5K | 68.6K |
| Earning Date | 11-09-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | ★ 71.43 | 15.38 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | N/A |
| Revenue This Year | $28.13 | $1.18 |
| Revenue Next Year | $56.02 | $3.29 |
| P/E Ratio | ★ N/A | $17.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.76 | $39.24 |
| 52 Week High | $54.98 | $53.60 |
| Indicator | HROW | CCBG |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 54.44 |
| Support Level | $27.75 | $50.36 |
| Resistance Level | $30.28 | $51.93 |
| Average True Range (ATR) | 1.66 | 1.21 |
| MACD | 0.31 | 0.02 |
| Stochastic Oscillator | 35.42 | 29.56 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.